2418
P. Del Buttero et al. / Tetrahedron 61 (2005) 2413–2419
1
s), 4.05 (1H, d, JZ3.3 Hz), 4.65 (1H, d, JZ3.3 Hz), 4.84
(1H, d, JZ6.3 Hz), 5.09 (1H, d, JZ6.3 Hz), 6.8–7.5 (18H,
m); MS m/z 638 (MC). Anal. Calcd for C34H28BrN3O5: C,
63.96; H, 4.42; N, 6.58. Found: C, 64.01; H, 4.45; N, 6.63.
1730 cmK1; H NMR (CDCl3) d 3.73 (6H, s), 4.50 (1H, d,
JZ4.9 Hz), 4.79 (1H, dd, JZ7.5, 4.9 Hz), 4.80–4.85 (2H,
m), 5.50 (1H, dd, JZ15.7, 3.8 Hz), 5.84 (1H, dd, JZ15.7,
7.5 Hz), 6.9–7.7 (18H, m); MS m/z 664 (MC). Anal. Calcd
for C36H30BrN3O5: C, 65.07; H, 4.55; N, 6.32. Found: C,
65.10; H, 4.51; N, 6.27.
Compound (4R*,40R*)-6b. (0.09 g, 14%) as pale yellow
powder, mp 182 8C (from diisopropyl ether). IR (nujol)
1
1745, 1730 cmK1; H NMR (CDCl3) d 3.73 (3H, s), 3.80
The mixture of compounds 11b and 12b was crystallised
with chloroform. Minor 12b was obtained as a crystalline
solid while the mother liquor contained major 11b.
(3H, s), 4.95 (1H, d, JZ6.6 Hz), 5.31 (1H, d, JZ4.1 Hz),
5.86 (1H, d, JZ6.6 Hz), 6.32 (1H, d, JZ4.1 Hz), 6.8–7.5
(18H, m); MS m/z 638 (MC). Anal. Calcd for
C34H28BrN3O5: C, 63.96; H, 4.42; N, 6.58. Found: C,
63.91; H, 4.46; N, 6.52.
Compound (4R*,40S*)-11b. (0.17 g, 25%). IR (nujol) 1745,
1730 cmK1; 1H NMR (CDCl3) d 3.74 (3H, s), 3.82 (3H, s),
3.86 (1H, dd, JZ8.5, 4.3 Hz), 4.85–4.90 (2H, m), 5.07 (1H,
d, JZ4.3 Hz), 5.45 (1H, dd, JZ15.7, 4.9 Hz), 6.02 (1H, dd,
JZ15.7, 8.5 Hz), 6.9–7.6 (18H, m); MS m/z 664 (MC).
Anal. Calcd for C36H30BrN3O5: C, 65.07; H, 4.55; N, 6.32.
Found: C, 65.14; H, 4.58; N, 6.37.
In the case of compounds 10a–13a (from 2-azetidinone 2),
first fractions gave major 10a, further elution gave a mixture
of 11a–13a.
Compound (4R*,40R*)-10a. (0.19 g, 31%). IR (nujol) 1740,
1730 cmK1; 1H NMR (CDCl3) d 2.29 (3H, s), 3.74 (3H, s),
3.82 (3H, s), 3.85 (1H, dd, JZ8.5, 4.4 Hz), 4.82–4.88 (2H,
m), 5.12 (1H, d, JZ4.4 Hz), 5.45 (1H, dd, JZ15.7, 5.0 Hz),
6.02 (1H, dd, JZ15.7, 8.5 Hz), 6.8–7.6 (18H, m); MS m/z
599 (MC). Anal. Calcd for C37H33N3O5: C, 74.11; H, 5.55;
N, 7.01. Found: C, 74.16; H, 5.58; N, 7.08.
Compound (4R*,50R*)-12b. (60 mg, 9%). Mp 186 8C (from
chloroform). IR (nujol) 1750, 1735 cmK1 1H NMR
;
(CDCl3) d 3.83 (6H, s), 4.58 (1H, d, JZ5.2 Hz), 4.75 (1H,
dd, JZ7.9, 5.2 Hz), 4.80–4.85 (2H, m), 5.48 (1H, dd, JZ
15.7, 3.5 Hz), 5.83 (1H, dd, JZ15.7, 7.9 Hz), 6.8–7.7 (18H,
m); MS m/z 664 (MC). Anal. Calcd for C36H30BrN3O5: C,
65.07; H, 4.55; N, 6.32. Found: C, 65.03; H, 4.55; N, 6.36.
The mixture of compounds 11a–13a was chromatographed
on a silica gel column with ethyl acetate/light petroleum 3:2.
First fractions gave major 11a, further elution gave a
mixture of minor 12a and 13a.
4.1.5. Cerium(IV) ammonium nitrate oxidation of major
cycloadducts 10b and 11b. A solution of 10b or 11b
(0.17 g, 0.26 mmol) in acetonitrile (15 mL) was cooled to
0 8C. Cerium(IV) ammonium nitrate (0.55 g, 1.0 mmol) in
water (8.0 mL) was added dropwise under vigorous stirring
and ice-cooling. The reaction was monitored by TLC
(eluent: light petroleum/ethyl acetate 3:2). After 2 h water
(15 mL) and saturated aqueous sodium dithionite (10 mL)
were added. The resulting mixture was extracted with ethyl
acetate (4!25 mL), the organic layer was washed with
water (2!25 mL) and dried over sodium sulfate. Evapor-
ation of the solvent under reduced pressure gave 14 as a dark
oil.
Compound (4R*,40S*)-11a. (0.19 g, 31%). IR (nujol) 1750,
1735 cmK1; 1H NMR (CDCl3) d 2.30 (3H, s), 3.72 (3H, s),
3.81 (3H, s), 3.89 (1H, dd, JZ8.0, 4.0 Hz), 4.80–4.86 (2H,
m), 5.19 (1H, d, JZ4.0 Hz), 5.50 (1H, dd, JZ15.6, 5.3 Hz),
6.01 (1H, dd, JZ15.6, 8.0 Hz), 6.7–7.8 (18H, m); MS m/z
599 (MC). Anal. Calcd for C37H33N3O5: C, 74.11; H, 5.55;
N, 7.01. Found: C, 74.08; H, 5.51; N, 6.94.
Compounds (4R*,50R*)-12a and (4R*,50S*)-13a (156 mg,
26%) were as 1:1 mixture on the basis of 1H NMR spectrum.
Diagnostic signals were at d 4.42 (1H, d, JZ5.0 Hz), first
minor diastereoisomer, and at d 4.57 (1H, d, JZ5.5 Hz),
second minor diastereoisomer.
Compound 14. (85 mg, 58%). IR (nujol) 1750, 1730 cmK1
;
1H NMR (CDCl3) d 3.99 (3H, s), 4.47 (1H, dd, JZ7.7,
5.2 Hz), 4.62 (1H, d, JZ5.2 Hz), 5.50 (1H, dd, JZ16.2,
7.7 Hz), 5.73 (1H, br s), 6.95 (1H, d, JZ16.2 Hz), 7.1–7.1
(14H, m); MS m/z 572 (MC). Anal. Calcd for
C29H22BrN3O4: C, 62.60; H, 3.99; N, 7.55. Found: C,
62.58; H, 3.97; N, 7.58.
In the case of compounds 10b–13b (from 2-azetidinone 2),
first fractions gave a mixture of major 10b and minor 13b,
further elution gave a mixture of major 11b and minor 12b.
The mixture of compounds 10b and 13b was chromato-
graphed on a silica gel column with dichloromethane/light
petroleum 9:1. First fractions gave major 10b, further
elution gave minor 13b.
Acknowledgements
Thanks are due to MURST and CNR for financial support.
We thank the NMR technician Dr. Lara De Benassuti,
University of Milan, for NOESY experiments.
Compound (4R*,40R*)-10b. (0.17 g, 25%). IR (nujol) 1745,
1730 cmK1; 1H NMR (CDCl3) d 3.81 (3H, s), 3.84 (3H, s),
3.87 (1H, dd, JZ7.9, 3.9 Hz), 4.82–4.88 (2H, m), 5.14 (1H,
d, JZ3.9 Hz), 5.50 (1H, dd, JZ15.7, 5.2 Hz), 6.01 (1H, dd,
JZ15.7, 7.9 Hz), 6.9–7.7 (18H, m); MS m/z 664 (MC).
Anal. Calcd for C36H30BrN3O5: C, 65.07; H, 4.55; N, 6.32.
Found: C, 65.12; H, 4.59; N, 6.39.
References and notes
Compound (4R*,50S*)-13b. (60 mg, 9%). IR (nujol) 1740,
1. Samarendra, C. I.; Maiti, N.; Micetich, R.; Daneshtalab, M.;